Dept. of Clinical Sciences/ Ophthalmology Umea University Hospital
Umeå, SE-901 85, Sweden
NCT Number: NCT00825513
The purpose of this study is to evaluate the safety and effectiveness of the Akreos Toric IOL following cataract surgery.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Phase 4
Umeå, SE-901 85, Sweden
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Lens implant following cataract surgery
Lens implant following cataract surgery
Time frame: 32 months
Time frame: 32 months
Bausch & Lomb Incorporated
Industry
Monocular Study to Evaluate the Safety and Effectiveness of the Akreos™ Toric IOL When Used to Correct Primary Aphakia With the Reduction of Astigmatism
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06399211
Aphakia, Aphakia, Postcataract
View Trial DetailsNCT06250855
Astigmatism, Cataract
Bacau, Romania
View Trial DetailsNCT07176897
Astigmatism, Cataract
Encino, California, United States
View Trial DetailsNCT04676451
Astigmatism, Cataract
Hershey, Pennsylvania, United States
View Trial Details